Insider · CIK 0001359820

Babcock Dwight William

Reports to the SEC for 1 company · TUCSON, AZ

sec.gov

Transactions

Companies

Filings

CIK

0001359820

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-11-12	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+23.8K sh	$1.27	+$30.2K	326,402
2015-11-12	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,000 sh	$1.26	+$1,260	302,602
2015-11-12	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+200 sh	$1.25	+$251	301,602
2015-06-18	CATXPerspective Therapeutics, Inc. · Stock optionsA Award	Director, CEO	AAward	+50K sh	—	—	50,000
2015-06-09	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+100 sh	$1.53	+$152.99	301,102
2015-06-09	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+300 sh	$1.52	+$457.5	301,402
2015-06-09	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+9,600 sh	$1.53	+$14.7K	301,002
2015-03-03	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+7,500 sh	$1.51	+$11.3K	291,402
2015-03-02	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+2,529 sh	$1.51	+$3,818.79	283,902
2013-11-01	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+25K sh	$0.53	+$13.3K	281,373
2013-09-05	CATXPerspective Therapeutics, Inc. · Stock OptionsA Award	Director, CEO	AAward	+50K sh	—	—	50,000
2012-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+500 sh	$0.40	+$199.95	253,873
2012-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+7,100 sh	$0.40	+$2,840	253,373
2012-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+2,500 sh	$0.40	+$999.25	256,373
2012-11-19	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,800 sh	$0.37	+$1,776	246,273
2012-11-16	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+100 sh	$0.37	+$37	241,473
2012-11-16	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+20K sh	$0.42	+$8,500	226,373
2012-11-16	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+5,000 sh	$0.42	+$2,099.5	231,373
2012-11-16	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$0.41	+$4,150	241,373
2012-06-27	CATXPerspective Therapeutics, Inc. · Stock OptionsP Purchase	Director, CEO	PPurchase	+50K sh	—	—	50,000
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,900 sh	$0.53	+$2,584.75	168,161
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+100 sh	$0.50	+$49.99	168,261
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,000 sh	$0.52	+$519.9	169,261
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,900 sh	$0.53	+$2,584.75	201,273
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+100 sh	$0.50	+$49.99	201,373
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,000 sh	$0.52	+$519.9	202,373
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,900 sh	$0.53	+$2,584.75	205,273
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+100 sh	$0.50	+$49.99	205,373
2012-03-22	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,000 sh	$0.52	+$519.9	206,373
2012-03-20	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,000 sh	$0.50	+$2,000	173,261
2012-03-20	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,000 sh	$0.50	+$2,000	200,373
2012-03-20	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+4,000 sh	$0.50	+$2,000	206,373
2012-02-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+500 sh	$0.51	+$255	163,261
2012-02-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+500 sh	$0.51	+$255	196,373
2012-02-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+500 sh	$0.51	+$255	196,373
2012-02-17	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$0.54	+$5,400	195,873
2012-02-17	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$0.54	+$5,400	162,761
2011-12-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$0.68	+$6,817.68	152,761
2011-12-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$0.68	+$6,817.68	185,873
2011-12-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$0.68	+$6,817.68	185,873
2011-12-20	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+9,974 sh	$0.68	+$6,782.32	175,847
2011-12-20	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+9,974 sh	$0.68	+$6,782.32	142,735
2011-12-20	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+9,974 sh	$0.68	+$6,782.32	175,847
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,100 sh	$0.85	+$934.89	165,773
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+400 sh	$0.84	+$336	164,673
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,100 sh	$0.85	+$934.89	165,773
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+100 sh	$0.85	+$85	165,873
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+400 sh	$0.84	+$336	164,673
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+400 sh	$0.84	+$336	131,561
2011-11-21	CATXPerspective Therapeutics, Inc.P Purchase	Director, CEO	PPurchase	+1,100 sh	$0.85	+$934.89	132,661

Recent filings

Accepted (ET)
Nov 134
IsoRay, Inc.0001359820-15-000004
SEC(opens sec.gov)
Jun 224
IsoRay, Inc.0001359820-15-000003
SEC(opens sec.gov)
Jun 94
IsoRay, Inc.0001359820-15-000002
SEC(opens sec.gov)
Mar 34
IsoRay, Inc.0001359820-15-000001
SEC(opens sec.gov)
Nov 54
IsoRay, Inc.0001359820-13-000002
SEC(opens sec.gov)
Sep 104
IsoRay, Inc.0001359820-13-000001
SEC(opens sec.gov)
Nov 214
Babcock Dwight William0001359820-12-000016
SEC(opens sec.gov)
Nov 214
Babcock Dwight William0001359820-12-000018
SEC(opens sec.gov)
Nov 214
Babcock Dwight William0001359820-12-000017
SEC(opens sec.gov)
Jul 94
Babcock Dwight William0001359820-12-000014
SEC(opens sec.gov)

Companies

Perspective Therapeutics, Inc.Director, CEOCATX

Address

6464 E GRANT ROAD

TUCSON, AZ, 85715